Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net revenue $ 58,410 $ 62,709
Operating expenses:    
Cost of revenue [1] 12,045 15,779
Selling and marketing 21,025 13,169
Research and development 14,724 13,674
General and administrative 9,436 11,861
Depreciation and amortization 9,833 9,632
Restructuring and related 4,652 1,335
Total operating costs and expenses 71,715 65,450
Loss from operations (13,305) (2,741)
Other income (expense), net:    
Change in fair value of warrant liabilities 18 101
Change in fair value of contingent consideration 2,780 (325)
Interest income, net 722 906
Other loss, net (281) (473)
Total other income, net 3,239 209
Loss before income taxes (10,066) (2,532)
Income tax expense (610) (348)
Net loss $ (10,676) $ (2,880)
Net loss per share attributable to Class A and Class B common stockholders:    
Basic (USD per share) $ (0.08) $ (0.02)
Diluted (USD per share) $ (0.08) $ (0.02)
Weighted average shares of common stock outstanding:    
Basic (shares) 127,660 125,253
Diluted (shares) 127,660 125,253
[1] Amounts exclude depreciation and amortization.